According to the Centers for Disease Control and Prevention, approximately 37.3 million Americans have diabetes, while ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...

Novo Nordisk today announced new real‑world evidence in adults with type 2 diabetes (T2D) treated with once‑weekly ...

A new study examining the role of continuous glucose monitoring (CGM) in the management of adults with type 2 diabetes who are not on insulin found that CGM substantially reduced hyperglycemia, ...

A large proportion of people living with type 2 diabetes treated with basal insulin therapy remain inadequately controlled ...

Doctors say the medication is designed to support healthier long-term routines rather than replace them.

The findings of this study are important because most research on type 2 diabetes focuses on people who are overweight or ...

Glucagon-like peptide-1 (GLP-1) agonists, or GLP-1s, were developed more than 20 years ago to treat type 2 diabetes. We now know that they can also help you manage your weight, improve metabolic ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

A new long-term study details how a common deep-fried snack could increase the risk of type 2 diabetes. Here are the forms of ...

Obesity and type 2 diabetes are closely linked. Excess body fat can alter your body’s metabolic system, promote insulin resistance, and trigger inflammatory responses that affect how well your body ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...